Extended list of
our Products
"The best way to predict the future is to create it"
Abraham Lincoln
this is what we do

Our mission in PharOS is to materialize in the most efficient way our customers trust, by ensuring that their products will be among

the first to be launched after patent expiry and the last ones to exit the market.

ACTIVE INGREDIENT
THERAPEUTIC CATEGORY
DELIVERY FORM
STRENGTH(S)
PREVIEW
IVABRADINE
CVS
Film Coated Tablet
5mg, 7.5mg
IVABRADINE
ENLARGE
ERLOTINIB
Oncology
Film Coated Tablet
25mg, 50mg, 100mg, 150mg
ERLOTINIB
ENLARGE
ABACAVIR/LAMIVUDINE
Antivirals
Film Coated Tablet
600mg / 300mg
ABACAVIR/LAMIVUDINE
ENLARGE
EMTRICITABINE/ TENOFOVIR DISOPROXIL
Antivirals
Film Coated Tablet
200mg / 245mg
EMTRICITABINE/ TENOFOVIR DISOPROXIL
ENLARGE
TENOFOVIR DISOPROXIL
Antivirals
Film Coated Tablet
123mg, 163mg, 204mg, 245mg
TENOFOVIR DISOPROXIL
ENLARGE
ETORICOXIB
NSAID
Film Coated Tablet
30mg, 60mg, 90mg, 120mg
ETORICOXIB
ENLARGE
CINACALCET
Hypercalcemia Hyperparathyroidism
Film Coated Tablet
30mg, 60mg, 90mg
CINACALCET
ENLARGE
* Availability of products is subject to patent restrictions in countries where applicable patents are in effect.
CONTACT
businessdevelopment
@pharosgr.gr
For our current
product pipeline